DZE: Implant, Endosseous, Root-Form
What it covers
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
The identification in 21 CFR 872.3640, endosseous dental implant. FDA gives DZE no definition of its own, so the regulation’s describes it.
FDA flags DZE devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261392 | TriActive Dental Implant System | Paragon Implant Mfg., LLC | Sep 17, 2026 | Abbreviated |
| K260463 | ZEROS Dental Implant System | Zeros Co., Ltd. | Aug 19, 2026 | Special |
| K251188 | UNIQA® Dental Implants System | Uniqa Dental, Ltd. | Jun 25, 2026 | Traditional |
| K251232 | MegaGen Zygoma Dental Implant System | Megagen Implant Co., Ltd. | Jun 18, 2026 | Traditional |
| K250806 | Dental Implant System | A.B. Dental Devices , Ltd. | Jun 18, 2026 | Traditional |
| K260006 | INOSS System | Inosys, Inc. | Jun 17, 2026 | Traditional |
| K252731 | Promimic ZrP Surface Dental Implant; Promimic ZrP + HAnano Surface Dental Implant | Promimic AB | May 12, 2026 | Traditional |
| K252031 | Adin Long Dental Implant System | Adin Dental Implant Systems , Ltd. | Mar 23, 2026 | Traditional |
| K253334 | ZENEX Implant System_Short (R-System) | Izenimplant Co., Ltd. | Mar 16, 2026 | Traditional |
| K252168 | Straumann® BLC Implants - Indication Widening | Institut Straumann AG | Mar 10, 2026 | Traditional |
Clearances by year
568 DZE 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 14 | 207 |
| 2025 | 31 | 184 |
| 2024 | 40 | 222 |
| 2023 | 35 | 248 |
| 2022 | 34 | 243 |
| 2021 | 34 | 182 |
| 2020 | 41 | 230 |
| 2019 | 31 | 231 |
| 2018 | 41 | 200 |
| 2017 | 48 | 223 |
| 2016 | 40 | 219 |
| 2015 | 36 | 215 |
| 2014 | 36 | 265 |
| 2013 | 42 | 195 |
| 2012 | 39 | 174 |
| 2011 | 26 | 194 |
Who submits
225 applicants cleared a DZE device since 2011. 35% of the clearances went to applicants in United States, then South Korea (21%), Israel (10%) and Switzerland (7%). By type: Traditional 90%, Special 5% and Abbreviated 5%.
| Applicant | Clearances since 2011 |
|---|---|
| Dentis Co., Ltd. | 16 |
| Institut Straumann AG | 16 |
| Megagen Implant Co., Ltd. | 16 |
| Jjgc Industria E Comercio DE Materiais Dentarios S.A. | 13 |
| Nobel Biocare AB | 13 |
| Southern Implants (Pty), Ltd. | 12 |
| Hiossen, Inc. | 11 |
| Innobiosurg Co., Ltd. | 10 |
How FDA classifies it
(1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
(2) Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:
(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
From 21 CFR 872.3640. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 872.3640 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DZE clearances declared.
Ask about DZE
Questions about DZE
What is FDA product code DZE?
Product code DZE, “Implant, Endosseous, Root-Form” in FDA's classification database, is a Class II device type under 21 CFR 872.3640 (endosseous dental implant), reviewed by FDA's Dental panel. FDA's 510(k) database lists 1,549 clearances under DZE, 568 of them since 2011.
How many 510(k) clearances are there under DZE?
FDA’s 510(k) database listed 1,549 clearances under DZE as of Oct 29, 2026, 568 of them decided since 2011; the most recent decision was Sep 17, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DZE 510(k)?
For the 57 DZE clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 193 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DZE clearances?
Since 2011: Dentis Co., Ltd. (16), Institut Straumann AG (16), Megagen Implant Co., Ltd. (16), Jjgc Industria E Comercio DE Materiais Dentarios S.A. (13) and Nobel Biocare AB (13). 225 applicants have cleared a DZE device in that time.